These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4346603)

  • 1. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 2. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis.
    Liberman B; Wajchenberg BL; Tambascia MA; Mesquita CH
    J Clin Endocrinol Metab; 1976 Oct; 43(4):913-8. PubMed ID: 185234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM
    N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    Crystal RG; Rose LI; Jagger PI; Lauler DP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
    [No Abstract]   [Full Text] [Related]  

  • 7. Anomalous response to metyrapone in Cushing's syndrome due to adrenocortical adenoma.
    Pennington LF; Kreisberg RA; Hershman JM
    J Clin Endocrinol Metab; 1970 Jan; 30(1):125-7. PubMed ID: 4311614
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of Cushing's disease with paradoxical response to dexamethasone].
    Kubo M; Nakagawa K; Akikawa K; Matsubara M; Ishizuka T; Nakagawa S
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):75-82. PubMed ID: 3009668
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.
    Rayyis SS; Bethune JE
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1231-7. PubMed ID: 4309156
    [No Abstract]   [Full Text] [Related]  

  • 11. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal rhythm in the response of urinary 17-OHCS to metopirone in Cushing's syndrome due to bilateral adrenal hyperplasia.
    Takebe K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):433-8. PubMed ID: 4685385
    [No Abstract]   [Full Text] [Related]  

  • 13. Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.
    Hermus AR; Pieters GF; Smals AG; Pesman GJ; Lamberts SW; Benraad TJ; van Haelst UJ; Kloppenborg PW
    N Engl J Med; 1988 Apr; 318(15):966-70. PubMed ID: 2832758
    [No Abstract]   [Full Text] [Related]  

  • 14. "Normal suppression" to dexamethasone in Cushing's disease: an expression of decreased metabolic clearance for dexamethasone.
    Caro JF; Meikle AW; Check JH; Cohen SN
    J Clin Endocrinol Metab; 1978 Sep; 47(3):667-70. PubMed ID: 233679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's syndrome with dual pituitary-adrenal control.
    Choi Y; Werk EE; Sholiton LJ
    Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
    Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
    J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and significance of the dexamethasone suppression test in Cushing's disease.
    N Engl J Med; 1967 Aug; 277(8):431. PubMed ID: 4378315
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercortisolism.
    Howanitz PJ; Howanitz JH
    Clin Lab Med; 1984 Dec; 4(4):683-702. PubMed ID: 6096077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations and comments on failure of dexamethasone suppression.
    Linn JE; Bowdoin B; Farmer TA; Meador CK
    N Engl J Med; 1967 Aug; 277(8):403-5. PubMed ID: 4378314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.